Neus Xiville-Ruiz

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

Journal: Blood advances

Published: January 20, 2026

Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma.

Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma.

Journal: American journal of hematology

Published: March 24, 2025

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols.

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols.

Journal: Medicina clinica

Published: January 24, 2025

Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study.

Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study.

Journal: Blood advances

Published: December 21, 2023

Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.

Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.

Journal: Genes, chromosomes & cancer

Published: July 28, 2021

Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.

Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.

Journal: Disease models & mechanisms

Published: December 07, 2020

Coexistence of JAK2V617F mutation and isolated del(5q) in a patient with thrombocytosis.

Coexistence of JAK2V617F mutation and isolated del(5q) in a patient with thrombocytosis.

Journal: Medicina clinica

Published: April 15, 2020

Cytogenetics in the genomic era.

Cytogenetics in the genomic era.

Journal: Best practice & research. Clinical haematology

Published: February 24, 2020

FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.

FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.

Journal: Cytometry. Part B, Clinical cytometry

Published: November 29, 2019

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

Journal: Blood

Published: September 02, 2018

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology

Published: May 07, 2018

Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.

Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: July 22, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026